Since the onset of the pandemic, Cerba Healthcare has been at the forefront of fighting against COVID-19 with all stakeholders — including patients, healthcare professionals, governments, IVD professionals, and pharmaceutical and biotechnology companies — developing vaccines and treatments. We’ve screened over 31,000 patients across five continents while helping to conduct COVID-19 treatment clinical trials in 14 countries.
Our COVID-19 testing services and exploratory tools help our partners develop more tailored and effective treatments:
Molecular Diagnostics for COVID-19
Detailed Look
Specimen Collection
Nasopharyngeal and Oropharyngeal Swabs and Saliva
TAT
Standard TAT Is 48-72 Hours Upon Samples Receipt
BSL
Precautions Biosafety Level 2
RT-PCR Assays on a Global Scale
- Roche: Cobas® SARS-CoV-2 Test
- Roche: Cobas® SARS-CoV-2 & Influenza A/B
- Roche: Cobas® Fosun COVID-19
- Abbott RealTime SARS-CoV-2 Assay
- BioRad Hamilton Covid-19 PCR
- PerkinElmer® SARS-CoV-2 Real-time RT-PCR Assay
- Panther system: Hologic Assay — the Panther Fusion SARS-CoV-2 Assay
- Abbott: Alinity m SARS-CoV-2 assay
- GenMark e-Plex Respiratory Pathogen Panel 2
- Seegene: Allplex 2019-nCov Assay
- Applied Biosystems: Takara SARS-CoV-2
- Elitech: Genefinder Covid-19 Plus RealAMP Kit
- ThermoFisher: TaqPath™ COVID 19
Digital PCR
- Bio-Rad SARS-CoV-2 ddPCR Kit
TMA
- Panther system: Aptima SARS-CoV-2 assay
NGS Testing for COVID-19
Specimen Collection
Nasopharyngeal and Oropharyngeal Swabs and Saliva
TAT
Standard TAT is 48-96 hours upon samples receipt
BSL
Precautions Biosafety Level 2
Advantages of NGS Testing
- Illumina sequencing (5-10 copies/µl at 95%)
- Development of antiviral therapies, vaccines
- Understand the origin of SARS-CoV-2
- Epidemiological investigation
- Identify new strains of the coronavirus and detect new mutations
Serology Testing for COVID-19
Testing Immune Response
Specimen Collection
Serum
TAT
Standard TAT Is 48-96 Hours Upon Samples Receipt
BSL
Precautions Biosafety Level 2
Our Serology Assays Available
- Dynex DSX — Diasorin CLIA LIASION® SARS-CoV-2: IgG
- Dynex DSX — Diasorin CLIA LIASION® SARS-CoV-2: IgM
- Roche Cobas — Elecsys SARS-CoV-2: Total Antibodies (IgA, IgG and IgM)
- Abbott Alinity – SARS-CoV-2: IgG
- Abbott Alinity – SARS-CoV-2: IgM
Viral culture and viral neutralization
Cerba Research offers a full range of services to support the SARS-CoV-2 research agenda. Therefore, we implemented viral culture of SARS-CoV-2. The virus is cultured in VERA-E6 cells in a BSL3 laboratory adhering to the required safety standards. Then viral culture is confirmed through SARS-CoV-2 amplification.
Viral culture is important to determine if the virus that has been detected is viable and therefore still infectious. This is important when determining the efficacy of treatment studies.
Specimen Collection
Swabs
TAT
Standard TAT Is 48-96 Hours Upon Samples Receipt
BSL
Precautions Biosafety Level 3
We are also performing viral neutralization assays which are used to determine antibody efficacy. We are using a direct culture method.